Growing awareness of hormone-driven cancer types is encouraging wider adoption of specialized treatment solutions. The Latin America cancer hormone therapy market is estimated to record a CAGR of 9.5% from 2025 to 2031. Cancer hormone therapy is an essential component of oncology treatment used primarily for hormone-sensitive cancers such as breast, prostate, and endometrial cancers. In Latin...